Download - BB MIC 301 lec6 032714
MIC301/MIC303/320 lecture 6 2014 1
INTRODUCTORY IMMUNOLOGY MIC 301/320: Block 3
SPRING 2014Lecture 6 = The Last
1
Take a Deep Breath
MIC301/MIC303/320 lecture 6 2014 2
3
Antigen Recognition by B-cells and T-cells is Distinct (“native” vs. a “little bit of antigen and a
little bit of MHC”)
MIC301/MIC303/320 lecture 6 2014
Antigen Chipping is Needed for T-cell Recognition and Activation
MIC301/MIC303/320 lecture 6 2014 4
Who is shredding and presenting?
MIC301/MIC303/320 lecture 6 2014 5
Eco-Shredder
Professional Shredder
all healthy cells
professional Ag
presenting cells:
DC>MF>B-cell
only
MHC
cla
ss I
MHC
I AN
D M
HC II
6
Antigen Capture by Antigen Presenting Cells and Their Activation of Th cells Determines the Specifics of the Adaptive Immune Response
MIC301/MIC303/320 lecture 6 2014
7
How does CTL activation really work? (Menage a Trois)
MIC301/MIC303/320 lecture 6 2014
MHC I–CD8/TCR+ costimulation
cytokine
MHC II–CD4/TCR+ costimulation
no costimulation for effector function!!!
How does B-cell activation really work?
(Menage a deux)
MIC301/MIC303/320 lecture 6 2014 8
Definitions (20)MHC molecules have two functions. They are essential for the adaptive immune system because they “display” peptides of an antigen for their recognition by T-cells. Human MHC is also known as HLA. But they were discovered and named as genetic loci that are the principal determinants of acceptance or rejection of tissue grafts between individuals. Individuals that are identical at their MHC loci will accept grafts. There are 3 biallelicly expressed class I and, respectively, class II genes.
9MIC301/MIC303/320 lecture 6 2014
(1) How can MHC molecules accommodate an unlimited number of
antigens ?
note that only ~3-4 anchor residues of the “chipped” antigen need to fit with a given MHC grooveMIC301/MIC303/320 lecture 6 2014 10
(2a) How can MHC accommodate an unlimited number of antigens ?
o three different types of molecules (A, B and C) are on each cell
o both alleles for each of the three types are coexpressed
o expressed by all “healthy” cells
o one individual has the same combination of HLAs on all cells
MIC301/MIC303/320 lecture 6 2014 11
(2b) How can MHC accommodate an unlimited number of antigens ?
o three different combinations of dimers (α + β) are on each cell
o both alleles for each of the three types are coexpressed
o one individual has the same combination dimers on all of his antigen presenting cells
MIC301/MIC303/320 lecture 6 2014 12
MIC301/MIC303/320 lecture 6 2014 13
Definitions (21)
Polymorphisms indicates that genes exist in a variety of versions (different alleles) each of which is present in a different individual. MHC/HLA comprises the most polymorphic gene cluster in humans. All alleles are inherited.
MIC301/MIC303/320 lecture 6 2014 14
Why has MHC Polymorphism Evolved?
Survival of Mankind
a threatening pathogene
population
MIC301/MIC303/320 lecture 6 2014 15
interacts with CD8 interacts with CD4
presents intracellular antigens or cell remnants
presents extracellular antigens
expressed by all cellsexpressed by antigen-
presenting cells (DC, B, macrophage
3x2 and 6x2 different gene loci for MHC I and, respectively, MHC II in each individual can accommodate an many distinct peptides
Summary of MHC features responsible for antigen presentation
MIC301/MIC303/320 lecture 6 2014 16
Discovery of MHC and its Polymorphism as an Antigen that is
Specific for Each Individual
??
MIC301/MIC303/320 lecture 6 2014 17
Differences of MHC, TCR and BCR/Abfunction MHC I MHC II TCR BCR/Abdisplay peptide peptide no no
recognition no no peptide +MHC
part ofnative protein
specialbinds also to
CD8(T cell kill)
binds also toCD4
(T cell help)
always receptor
receptor and secreted effector
molecules on single cell
3 x 2 distinct alleles
3 x 2 distinct allelic pairs
single species unique
single speciesunique
variability in single human
3 distinctpolymorphic
genes
6 distinct polymorphic
genes
diversity >1016
diversity >1x1011
generated by inheritance inheritance recombination recombination
MIC301/MIC303/320 lecture 6 2014 18
Superantigens overpower the immune system (bind to a common region of MHC II
and to 5-30% of all TCRs
Take a Deep Breath
MIC301/MIC303/320 lecture 6 2014 19
MIC301/MIC303/320 lecture 6 2014 20
Vaccination and the Immune System (a)
active vaccinatio
n
immunity
functional immune system
MIC301/MIC303/320 lecture 6 2014 21
Definitions (22)
Adjuvant is a substance, distinct from the antigen or a pathogens, that promotes the accumulation and activation of antigen-presenting cells at the site of antigen exposure. It acts as the “danger” signal that TLRs promote. It is the “little dirty secret of immunology.”
MIC301/MIC303/320 lecture 6 2014 22
APCs “translate” that antigens are dangerous (rather than harmless self) because their danger signals
induce costimulation
coactivation
MIC301/MIC303/320 lecture 6 2014 23
Vaccination and the Immune System (b)
active vaccinatio
n
dysfunctional immune system
MIC301/MIC303/320 lecture 6 2014 24
Vaccination and the Immune System (c)
passive vaccinatio
n
dysfunctional immune system
temporarily
MIC301/MIC303/320 lecture 6 2014 25
Active versus passive vaccination
MIC301/MIC303/320 lecture 6 2014 26
Two Principles of Hypersensitivity
autoantigen
allergy
autoimmunity
foreign but harmless antigen
27
Possibilities for dealing with “autoimmune” lymphocytes
autoimmune cells suicide during development
(clonal deletion)
1
unable to activate if there is no
“danger” or if there is no signal 2
(anergy)
2MIC301/MIC303/320 lecture 6 2014
negative function (regulatory T-cells)
3
MIC301/MIC303/320 lecture 6 2014 28
Clonal deletion = Negative selection = Central tolerance
B-cells: Bone
marrow T-cells: Thymus
1
MIC301/MIC303/320 lecture 6 2014 29
Induction of Anergy
2
MIC301/MIC303/320 lecture 6 2014 30
Development of regulatory T-cells (TRegs)
3
MIC301/MIC303/320 lecture 6 2014 31
Blocking Tregs Strongly Activate the Immune System
“It took the past two decades for researchers to identify the braking mechanism, a molecule called CTLA-4, and develop a compound that gets the immune system to lift its foot off this brake enough to sufficiently attack melanoma, said James Allison, chairman of Memorial Sloan-Kettering Cancer Center's immunology program, whose research on the CTLA-4 molecule's role paved the way for ipilimumab's development.”
3
MIC301/MIC303/320 lecture 6 2014 32
Definitions (23)
Tolerance is the normal ability of the immune system to prevent self-destruction = autoimmune diseases. It is achieved by clonal deletion (thymus, bone marrow), generation of regulatory T-cells (thymus) and the induction of anergy (periphery). Large tumors can exploit regulatory T-cells and anergy against tumor antigens for their own good.
fore
ign
dang
ero
us
antig
ens
self
antig
ens
or
harm
less
an
tigen
s
33
Desired versus UndesiredAdaptive Immune Responses
reaction
no reactionMIC301/MIC303/320 lecture 6 2014
MIC301/MIC303/320 lecture 6 2014 34
Molecules and Cells Causing of Hypersensitivity Reactions
antibodies T-cells
time until onset
other than IgE
IgGcomplex
es
usually allergy usually
autoimmunity
example 1example 2
MIC301/MIC303/320 lecture 6 2014 35
Type IV Hypersensitivity is mediated by T-cells
Examples:Type I diabetesRheumatoid arthritisInflammatory bowel diseases
MIC301/MIC303/320 lecture 6 2014 36
Differences in the Fc region of the Abs (same specificity but different “isotype”) promote
unique functions
}Fc regiondi
ffere
nt e
ffect
or fu
nctio
ns
o Complement activation (IgM)
o Phagocyte receptor binding = opsonizing (IgG and IgE)
o Localisation in body (placenta crossing = neonatal immunity (IgG), breast milk, gut and respiratory tract IgA)
o Mastcell receptor binding (IgE)
37
Definitions (24)The isotype of an antibody is determined by
its constant region. B-cells can change their isotype in an ordered sequence during an immune response (but not their specificity). Isotypes can switch orderly from IgM to IgG to IgA and, finally, to IgE. This does not change the specificity of the antibody but it effects its function including its biological distribution, its interaction with complement and its binding to different Fc receptors. Thus antibodies have two biologically critical regions: The specific antigen recognition site and the Fc-region of their isotype shared with different specific antibodies.
MIC301/MIC303/320 lecture 6 2014
Type I hypersensitivity
(immediate)
http://upload.wikimedia.org/wikipedia/commons/c/ce/Mast_cells.jpg
38MIC301/MIC303/320 lecture 6 2014
MIC301/MIC303/320 lecture 6 2014 39
Any Questions?I will be outside the lecture room after
packing up